Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Jun 03, 2019 - Here are the biggest calls on Wall Street on Monday
Jun 03, 2019 - Oppenheimer issues rating change for TEVA
May 31, 2019 - Biogen (BIIB) announces new interim results from phase III EVOLVE-MS-1 study, which showed that the diroximel fumarate was generally well tolerated in people with relapsing MS.
May 30, 2019 - Here are the biggest calls on Wall Street on Thursday
May 29, 2019 - "Now that people are really freaking out ... I think it's time to start picking up stocks into weakness," Jim Cramer says.
May 29, 2019 -
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares have been under pressure since mid-May, when it was accused along with other generic companies for inflati
May 29, 2019 - An honest appraisal of the situation facing Teva.A discussion of Teva's lawsuits.An estimation of Teva's normalized FCF.Why Teva today is dramatically undervalued.
May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.